不孕治疗药的全球市场规模调查&预测:药物类别，终端用户，流通管道，地区分析，2022-2029年

所谓不孕治疗药是一组用于治疗不孕症和改善生殖功能的药物。

由于医疗保健意识的提高、女性老龄化以及患有压力和生活方式相关疾病的男女比例增加，预计生育药物市场将显着扩大。

本调查的目的是定义近年来各个细分市场和国家的市场规模，并在未来几年预测它们的价值。本报告设计内容涵盖调查对像国家产业的定性和定量双方面。

此外也提供市场未来性的成长促进因素和课题等重要方面相关之详细资讯。再加上主要企业的竞争情形和提供产品之详细分析，并涵括利害关係者投资所需的微观市场潜在机会。详细的市场区隔和子区隔如下列。

各药物类别

促性腺激素

芳香酶抑制剂

选择性雌激素受体调节(SERMs)

双胍

其他的药物类别

各终端用户

男性

女性

各销售管道

医院内药局

零售店

其他的流通管道

各地区

北美

美国

加拿大

欧洲

英国

德国

法国

西班牙

义大利

其他欧洲

亚太地区

中国

印度

日本

澳洲

韩国

其他亚太地区

南美

巴西

墨西哥

全球其他地区

目录

第1章 摘要整理

• 市场概述
• 世界·各分类市场估计·预测，2019-2029年
  • 不孕治疗药市场(各地区):2019-2029年
  • 不孕治疗药市场(各药物类别):2019-2029年
  • 不孕治疗药市场:各终端用户，2019-2029年
  • 不孕治疗药市场:各流通管道，2019-2029年
• 主要趋势
• 调查手法的介绍
• 调查前提条件

第2章 不孕治疗药的全球市场:定义和范围

• 调查的目的
• 市场定义和范围
  • 调查目标范围
  • 产业的演进
• 调查对像年
• 货币换算比率

第3章 不孕治疗药的全球市场动态

• 不孕治疗药市场影响分析(2019-2029年)
  • 推动市场要素
  • 市场课题
  • 市场机会

第4章 不孕治疗药的全球市场:产业分析

• 波特的5力模式
  • 供给企业谈判力
  • 买方议价能力
  • 新加入厂商业者的威胁
  • 替代品的威胁
  • 竞争企业间的敌对关係
• 波特五力分析的未来性方法(2019-2029年)
• PEST分析
  • 政治
  • 经济
  • 社会
  • 技术性
• 投资采用模式
• 分析师的结论·建议
• 顶级投资机会
• 主要成功策略

第5章 风险评估:COVID-19衝击

• COVID-19对产业带来的整体影响的评估
• COVID-19以前和COVID-19以后的市场情景

第6章 不孕治疗药的全球市场:各药物类别

• 市场概述
• 不孕治疗药的全球市场:各药物类别，业绩-潜在力分析
• 不孕治疗药的全球市场，各药物类别估计·预测2019-2029
• 不孕治疗药市场，子区隔分析
  • 促性腺激素
  • 芳香酶抑制剂
  • 选择性雌激素受体调节(SERMs)
  • 双胍
  • 其他的药物类别

第7章 不孕治疗药的全球市场:各终端用户

• 市场概述
• 不孕治疗药的全球市场:各终端用户实际成果-潜在力分析
• 不孕治疗药的全球市场，各终端用户估计·预测2019-2029
• 不孕治疗药市场，子区隔分析
  • 男性
  • 女性

第8章 不孕治疗药的全球市场:各流通管道

• 市场概述
• 不孕治疗药的全球市场:各流通管道实际成果-潜在力分析
• 不孕治疗药的全球市场，各流通管道估计·预测(2019-2029年
• 不孕治疗药市场，子区隔分析
  • 医院内药局
  • 零售药局
  • 其他的流通管道

第9章 不孕治疗药的全球市场:各地区分析

• 不孕治疗药的市场，各地区市场概述
• 北美
  • 美国
    • 各药物类别的估计·预测，2019年～2029年
    • 各终端用户的估计·预测，2019年～2029年
    • 各流通管道的估计·预测，2019年～2029年
  • 加拿大
• 欧洲的不孕治疗药市场概述
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 义大利
  • 其他的欧洲地区
• 亚太地区的不孕治疗药市场概述
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 其他亚太地区
• 南美的不孕治疗药市场概述
  • 巴西
  • 墨西哥
• 全球其他地区

第10章 竞争资讯

• 顶级市场策略
• 企业简介
  • Teva Pharmaceuticals Industries
    • 主要的资讯
    • 概要
    • 财务(视资料可得性)
    • 产品概要
    • 最近的开发情形
  • Abbott Laboratories
  • Mankind Pharma
  • Merck KGaA
  • Ferring Pharmaceuticals Inc.
  • Novartis International AG
  • Livzon
  • Pfizer Inc.
  • Theramex
  • Bayer AG

第11章 调查流程

• 调查流程
  • 资料探勘
  • 分析
  • 市场估计
  • 验证
  • 出版
• 调查属性
• 调查前提条件

Global Infertility Drugs Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast period 2022-2029. The term "infertility medicines" refers to a group of pharmaceuticals that are used to treat infertility and improve a person's reproductive health. They can be swallowed or administered intravenously. Gonadotrophins, dopamine agonists, aromatase inhibitors, biguanides, ovulatory stimulants, selective oestrogen receptor modulators (SERMs), and tricyclic antidepressants are a few of the medications that are frequently used to treat infertility. The infertility drugs market is anticipated to expand significantly owing to upsurge in Healthcare Awareness along with increasing aging female population and growing prevalence of stress and life-style disorders among men and women.

The National Center for Drug Abuse Statistics found that during the COVID-19 lockdowns, almost 60.0% of Americans increased their alcohol intake. In a similar vein, according to a study issued by the World Health Organization in 2021, China had more than 300.0 million smokers, or over one-third of the world's population at the time. In China, there were around 26.6% of adults who smoked who were 15 years of age or older. One of the major contributors to hormonal imbalance, polycystic ovarian disease, and weight problems, which have an immediate influence on the embryo and might cause infertility concerns, is a healthy lifestyle. On the other side, over the past 16 years, the percentage of males with a normal total motile sperm count has decreased by around 10%. The evidence is clear: Men today generate less and less healthy sperm than in the past. However, strict regulatory structure that impedes the approval of products stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Infertility Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to menopausal disorders and high concentration of market players or manufacturer's presence. However, Asia Pacific expected to be the fastest growing region owing to rising healthcare expenditures and initiatives by the government to increase the availability of the infertility treatment in the developing nations.

Major market players included in this report are:

Abbott Laboratories

Ferring Pharmaceuticals Inc.

Merck KGaA

Pfizer Inc.

Novartis International AG

Bayer AG

Theramex

Mankind Pharma

Teva Pharmaceuticals Industries

Livzon

Recent Developments in the Market:

• In order to sell Genea Biomedx's (Australia) fertility products in the US and Canada, Genea Biomedx (Australia) partnered with Hamilton Thorne in 2020.
• In August 2021, Merck introduced Pergoveris Pen in India for the treatment of infertility. The Pergoveris Pen is the first item to ever include both recombinant follicle-stimulating hormone and recombinant luteinizing hormone in a ready-to-use, IVF specialist-prescribed device. A pen with bulk technology that has received international approval offers infertile couples a more secure self-service infertility option.

Global Infertility Drugs Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drug class, End User, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Gonadotrophins

Aromatase Inhibitors

Selective Estrogen Receptor Modulators (SERMs)

Biguanides

Other Drug Classes

By End User:

Male

Female

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Other Distribution Channels

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Infertility Drugs Market, by region, 2019-2029 (USD Billion)
  • 1.2.2. Infertility Drugs Market, by Drug Class, 2019-2029 (USD Billion)
  • 1.2.3. Infertility Drugs Market, by End User, 2019-2029 (USD Billion)
  • 1.2.4. Infertility Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Infertility Drugs Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Infertility Drugs Market Dynamics

• 3.1. Infertility Drugs Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Upsurge in Healthcare Awareness along with Increasing Aging Female Population
    • 3.1.1.2. Growing Prevalence of Stress and Life-style Disorders among Men and Women
  • 3.1.2. Market Challenges
    • 3.1.2.1. Strict Regulatory Structure that Impedes the Approval of Products
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising incidences of infertility and miscarriage
    • 3.1.3.2. Increasing public funding for developing these drugs

Chapter 4. Global Infertility Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Infertility Drugs Market, by Drug Class

• 6.1. Market Snapshot
• 6.2. Global Infertility Drugs Market by Drug Class, Performance - Potential Analysis
• 6.3. Global Infertility Drugs Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
• 6.4. Infertility Drugs Market, Sub Segment Analysis
  • 6.4.1. Gonadotrophins
  • 6.4.2. Aromatase Inhibitors
  • 6.4.3. Selective Estrogen Receptor Modulators (SERMs)
  • 6.4.4. Biguanides
  • 6.4.5. Other Drug Classes

Chapter 7. Global Infertility Drugs Market, by End User

• 7.1. Market Snapshot
• 7.2. Global Infertility Drugs Market by End User, Performance - Potential Analysis
• 7.3. Global Infertility Drugs Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
• 7.4. Infertility Drugs Market, Sub Segment Analysis
  • 7.4.1. Male
  • 7.4.2. Female

Chapter 8. Global Infertility Drugs Market, by Distribution Channel

• 8.1. Market Snapshot
• 8.2. Global Infertility Drugs Market by Distribution Channel, Performance - Potential Analysis
• 8.3. Global Infertility Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 8.4. Infertility Drugs Market, Sub Segment Analysis
  • 8.4.1. Hospital Pharmacies
  • 8.4.2. Retail Pharmacies
  • 8.4.3. Other Distribution Channels

Chapter 9. Global Infertility Drugs Market, Regional Analysis

• 9.1. Infertility Drugs Market, Regional Market Snapshot
• 9.2. North America Infertility Drugs Market
  • 9.2.1. U.S. Infertility Drugs Market
    • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. End User breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Infertility Drugs Market
• 9.3. Europe Infertility Drugs Market Snapshot
  • 9.3.1. U.K. Infertility Drugs Market
  • 9.3.2. Germany Infertility Drugs Market
  • 9.3.3. France Infertility Drugs Market
  • 9.3.4. Spain Infertility Drugs Market
  • 9.3.5. Italy Infertility Drugs Market
  • 9.3.6. Rest of Europe Infertility Drugs Market
• 9.4. Asia-Pacific Infertility Drugs Market Snapshot
  • 9.4.1. China Infertility Drugs Market
  • 9.4.2. India Infertility Drugs Market
  • 9.4.3. Japan Infertility Drugs Market
  • 9.4.4. Australia Infertility Drugs Market
  • 9.4.5. South Korea Infertility Drugs Market
  • 9.4.6. Rest of Asia Pacific Infertility Drugs Market
• 9.5. Latin America Infertility Drugs Market Snapshot
  • 9.5.1. Brazil Infertility Drugs Market
  • 9.5.2. Mexico Infertility Drugs Market
• 9.6. Rest of The World Infertility Drugs Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Teva Pharmaceuticals Industries
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Abbott Laboratories
  • 10.2.3. Mankind Pharma
  • 10.2.4. Merck KGaA
  • 10.2.5. Ferring Pharmaceuticals Inc.
  • 10.2.6. Novartis International AG
  • 10.2.7. Livzon
  • 10.2.8. Pfizer Inc.
  • 10.2.9. Theramex
  • 10.2.10. Bayer AG

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Infertility Drugs Market, report scope
• TABLE 2. Global Infertility Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Infertility Drugs Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
• TABLE 4. Global Infertility Drugs Market estimates & forecasts by End User 2019-2029 (USD Billion)
• TABLE 5. Global Infertility Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 6. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Infertility Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Infertility Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. U.S. Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 20. Canada Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. Canada Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 23. UK Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. UK Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 26. Germany Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. Germany Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 29. France Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. France Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 32. Italy Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Italy Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 35. Spain Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. Spain Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 38. RoE Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. RoE Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 41. China Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. China Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 44. India Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. India Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 47. Japan Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. Japan Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 50. South Korea Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. South Korea Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 53. Australia Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. Australia Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 59. Brazil Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Brazil Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 62. Mexico Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. Mexico Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 65. RoLA Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. RoLA Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Infertility Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 68. Row Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. Row Infertility Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Infertility Drugs Market
• TABLE 71. List of primary sources, used in the study of global Infertility Drugs Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Infertility Drugs Market, research methodology
• FIG 2. Global Infertility Drugs Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Infertility Drugs Market, key trends 2021
• FIG 5. Global Infertility Drugs Market, growth prospects 2022-2029
• FIG 6. Global Infertility Drugs Market, porters 5 force model
• FIG 7. Global Infertility Drugs Market, pest analysis
• FIG 8. Global Infertility Drugs Market, value chain analysis
• FIG 9. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Infertility Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Infertility Drugs Market, regional snapshot 2019 & 2029
• FIG 15. North America Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Infertility Drugs Market 2019 & 2029 (USD Billion)
• FIG 19. Global Infertility Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable